Whitehawk Therapeutics
WHWK
70 hedge funds and large institutions have $107M invested in Whitehawk Therapeutics in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 13 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 18
4.03% less ownership
Funds ownership: 62.71% → 58.68% (-4%)
8% less funds holding
Funds holding: 76 → 70 (-6)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
30% less call options, than puts
Call options by funds: $14K | Put options by funds: $20K
44% less capital invested
Capital invested by funds: $192M → $107M (-$85.2M)
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$4.89M |
| 2 |
DMKJ
David M. Knott Jr
|
+$1.67M |
| 3 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$812K |
| 4 |
Renaissance Technologies
New York
|
+$796K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$646K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$9.81M |
| 2 |
ABG
Ally Bridge Group
New York
|
-$8.12M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$3.23M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$2.61M |
| 5 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$831K |
WHWK Hedge Fund Activity: Q1 2023 in Review
70 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q1 2023, worth a combined $107M — down 44% from $192M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of WHWK and 7 opened new positions — a net loss of 6 holders — while 18 trimmed existing stakes and 22 added.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $4.89M. The largest seller was RTW Investments, exiting entirely with an estimated $9.81M sold.
- 70 institutional investors held Whitehawk Therapeutics (WHWK) as of Q1 2023, down from 76 in Q4 2022.
- Funds reported $107M of Whitehawk Therapeutics stock for Q1 2023, down 44% quarter-over-quarter.
- 7 funds opened new Whitehawk Therapeutics positions in Q1 2023 and 13 closed out, a net change of -6 holders.
- The largest Whitehawk Therapeutics buyer in Q1 2023 was Janus Henderson Group, an estimated $4.89M added.
- The largest Whitehawk Therapeutics seller in Q1 2023 was RTW Investments, an estimated $9.81M sold.
Based on aggregated 13F filings for Q1 2023.